The co-amplification of CDK4/MDM2 has also been noted to change the location and clinical features of rare cases of inflammatory myofibroblastic tumors, causing them to be mistaken for gastric cancer with local invasion of the spleen and diaphragm55. Here, MDM2 is linked to inflammatory myofibroblastic tumor.